Form 4 holding
Chief Development Officer
Crinetics Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 176,995
- Estimated value
- $6,663,862
- Report date
- 01 Mar 2022
- Price
- $37.65
- Ownership
- Direct
Ajay Madan - Chief Development Officer at Crinetics Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- Chief Development Officer
- Issuer symbol
- CRNX on Nasdaq
- Entity type
- Individual
- SEC filing history
- Open SEC filing history
Identity
1 identity field
Source evidence
1 source field
No buys or sells have been reported by Ajay Madan since 02 Jun 2025
Reported holdings for Ajay Madan in Crinetics Pharmaceuticals, Inc.
Form 4 holding
Chief Development Officer
Crinetics Pharmaceuticals, Inc.
- Security class
- Common Stock (right to buy)
- Shares / value
- 65,400
- Estimated value
- $1,119,648
- Report date
- 28 Feb 2022
- Price
- $17.12
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Ajay Madan in Crinetics Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.